# KCAS Bio: Science Accelerated

> KCAS Bio is a leading Bioanalytical CRO provider with a proven record of drug development worldwide across complex therapeutic modalities\.

Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Our Approach](https://kcasbio.com/about-us/our-approach/): KCAS Bio is a global bioanalytical CRO with comprehensive offerings in large and small molecule development\.
- [Our People](https://kcasbio.com/about-us/our-people/): Meet our team, who bring a wealth of knowledge, experience and understanding to build trusted client relationships and accelerate the process of bringing life\-changing drugs to market\.
- [About Us](https://kcasbio.com/about-us/): KCAS Bio is a full\-service bioanalytical and biomarker contract research organization \(CRO\), helping scientific innovators and investors to drive time\-critical research forward every day\.
- [EcoVadis Commitment](https://kcasbio.com/about-us/quality-commitment/ecovadis-commitment/): Although the Quality Department is independent of Laboratory Operations, both areas work within a culture of quality to achieve regulatory compliance, meet quality requirements and satisfy client expectations\. Quality is built into our DNA and is every employee’s responsibility\.
- [Sustainability \& Corporate Responsibility](https://kcasbio.com/about-us/sustainability-and-corporate-responsibility/): As a trusted bioanalytical CRO, we hold ourselves to the same rigorous standards in our business practices as we do in our science\. Our CSR and ESG commitments reflect our dedication to long\-term partnerships built on integrity, sustainability, and accountability\.

## Posts
- [Podcast \(The Conversational Flow\) Eps \#31: “The Next Generation of CAR\-T and AI\-Driven Discovery”](https://kcasbio.com/podcasts/tcf-031/)
- [Podcast \(The Weekly Bioanalysis\) Eps \#100: "6 Years \& 100 Episodes: What in the World Has Happened?"](https://kcasbio.com/podcasts/twb-100/)
- [ICCS 2026](https://kcasbio.com/events/iccs/)
- [26th International Mass Spectrometry Conference \(IMSC\)](https://kcasbio.com/events/international-mass-spectrometry-conference/)
- [Tracking the Immune Footprint of a Novel Cancer Vaccine: Insights from a Phase 1/2 Oncology Study](https://kcasbio.com/blogs/tracking-the-immune-footprint-of-a-novel-cancer-vaccine/)

## Services
- [Antibody Drug Conjugates](https://kcasbio.com/services/large-molecule-bioanalysis-by-lba/antibody-drug-conjugates/): KCAS Bio supports the development and characterization of Antibody–Drug Conjugates \(ADCs\) by providing comprehensive bioanalytical services\. This includes customized solutions based on our LBA and Hybrid/LC\-MS expertise, ensuring precise evaluation of ADC quantification, efficacy, stability, and safety across preclinical and clinical development stages\.
- [Small Molecule Bionalysis Services](https://kcasbio.com/services/small-molecule-bioanalytical-assays/): KCAS Bio provides GLP/GCP\-compliant small molecule bioanalysis using advanced LC\-MS/MS platforms and 40\+ years of expertise to quantify drugs, metabolites, and biomarkers from discovery through clinical stages\. We serve as an extension of your laboratory team, developing customized methods that generate precise, regulatory\-ready data to accelerate your therapeutic programs\.
- [Oligonucleotide Bioanalysis](https://kcasbio.com/services/oligonucleotide-bioanalysis-services/): KCAS Bio provides integrated oligonucleotide bioanalysis services across discovery, preclinical, and clinical development using LC\-MS/MS, HRMS, molecular, and biomarker platforms to characterize oligonucleotide therapeutics and address key analytical challenges\.
- [Pharmacodynamics](https://kcasbio.com/services/pd-services/): KCAS Bio provides bioanalytical services supporting pharmacodynamic \(PD\) studies across preclinical and clinical development\. Services focus on measuring the biological effects of a drug at its target, enabling evidence\-based decisions on efficacy, safety, and dose selection\.
- [Pharmacokinetics](https://kcasbio.com/services/pk-services/): KCAS Bio provides bioanalytical services supporting pharmacokinetic \(PK\) studies across preclinical and clinical development\. Services focus on the quantitative bioanalysis using validated and fit\-for\-purpose analytical methods\.

## Therapeutic Areas
- [Gastrointestinal](https://kcasbio.com/therapeutic-areas/gastrointestinal/): Gastrointestinal disorders include various conditions such as IBD \(like Crohn's disease and ulcerative colitis\), IBS, GERD and Celiac Disease\. KCAS Bio has extensive experience in conducting gastrointestinal studies\. Our team is made up of dedicated drug development experts with significant experience in conducting studies for experimental therapeutics for diseases and conditions that include everything from acid reflux and indigestion to IBS and Celiac\.
- [Respiratory](https://kcasbio.com/therapeutic-areas/respiratory/): KCAS can monitor the status of the immune system both during and after respiratory infection to understand the infection/recovery pathway, evaluate relapse factors versus true recovery, and the mechanism of cytokine response\. Ready to perform molecular testing, flow cytometric immunophenotyping, cytokine profiling in vitro and in vivo, as well as retrospective studies, KCAS has experience with whole blood, fresh, frozen or fixed PBMCs, lymphoid tissue, respiratory samples, serum, and plasma\.
- [Oncology](https://kcasbio.com/therapeutic-areas/oncology/): KCAS Bio has the expertise to support the Immuno\-oncology field\. We have expertise in flow cytometry, ELISPOTs, cell based assays and multiple biomarkers for the development of new drugs\. Whether it is in\-vitro discovery method or support of a phase III trial, we can assist you\. We provide reliable and defendable data while continuing to help our partners develop drugs for the advancement of world health\.
- [Renal](https://kcasbio.com/therapeutic-areas/renal/): The team at KCAS has expertise in developing renal/kidney testing that results in quality data for our customers\. In fact, KCAS has been called upon in the past to develop challenging assays for our clients who have had issues with the solubility of their compounds in the kidney\. Our knowledge and experience allows these customers to continue developing their drugs with a full understanding of the role renal function plays in that development\.
- [Rare Diseases](https://kcasbio.com/therapeutic-areas/rare-diseases/): There are a number of considerations when developing an assay to monitor a class of biomarkers for orphan or rare diseases\. KCAS has validated an assay for 20 amino acids \(20\-plex\) that has been applied to support studies in metabolism and rare disease\. KCAS is interested in increasing our suite of biomarker assays\. We are happy to develop and qualify custom methods or collaborate on more general assays for rare/orphan diseases\.

## Technology
- [Hybrid LC\-MS/MS](https://kcasbio.com/technology/hybrid-lcms-ms/): KCAS Bio has a team of experts specializing in hybrid Liquid Chromatography Mass Spectrometry \(LC\-MS/MS\)\. With deep knowledge and broad and experience, they quickly adapt experiment approaches when issues arise\.
- [Ligand Binding Assays](https://kcasbio.com/technology/ligand-binding-assays/): With extensive experience in ligand binding assays \(LBA\), advanced technological capabilities, and highly trained personnel, KCAS Bio closely collaborates with clients to offer a wide range of approaches to develop LBA methods spanning from the initial discovery phase to clinical studies\.
- [NULISA \- Argo HT](https://kcasbio.com/technology/nulisa-argoht/): KCAS Bio offers advanced proteomic services powered by the ARGO HT system™ and NULISA™ technology, delivering high\-plex and custom assays with unmatched sensitivity for biomarker discovery and translational research\.
- [Lupimulse G](https://kcasbio.com/technology/lumipulse/): Whether you’re advancing translational research or supporting late\-stage biomarker programs, the LUMIPULSE® G1200 offers a fully automated, high\-throughput immunoassay platform designed to deliver sensitive, reliable biomarker data\.
- [Liquid Chromatography Mass Spectrometry](https://kcasbio.com/technology/lcms-ms/): KCAS has a team of experts specializing in hybrid Liquid Chromatography Mass Spectometry \(LC\-MS/MS\)\. With deep knowledge and broad and experience, they quickly adapt experiment approaches when issues arise\.

## Categories
- [Blogs](https://kcasbio.com/blogs/)
- [Events](https://kcasbio.com/events/)
- [Podcasts](https://kcasbio.com/podcasts/)
- [Videos](https://kcasbio.com/videos/)
- [Podcasts \- The Weekly Bioanalysis](https://kcasbio.com/podcasts/the-weekly-bioanalysis/)

## Tags
- [Flow Cytometry](https://kcasbio.com/tag/flow-cytometry/)
- [Biomarkers](https://kcasbio.com/tag/biomarkers/)
- [About KCAS Bio](https://kcasbio.com/tag/about-kcasbio/)
- [Hybrid LC\-MS/MS](https://kcasbio.com/tag/hybrid-lc-ms-ms/)
- [Ligand Binding Assays \(LBA\)](https://kcasbio.com/tag/ligand-binding-assays-lba/)

## Optional
- [Sitemap index](https://kcasbio.com/sitemap_index.xml)